Sign in
4

Changes in Ownership

NEUROONE MEDICAL TECHNOLOGIES Corp Filed Acc 0001596771-21-000006

Options or other derivatives

  • Chief Technology Officer acquired 70,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mertens Steve · Chief Technology Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-01-27 Grant or award : show line 1 in the form Option to Purchase Common Stock +70,000 $1.99 2031-01-27 70,000 70,000 D
Loading xslF345X03/primary_doc.xml…